Stryker Corp Stock Forecast for 2023 - 2025 - 2030
Updated on 02/05/2023
Stryker Corp Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for Stryker Corp were recently set by four distinguished experts, with an average mark of $260.00. If it reached this goal, it would represent a potential downside of approximately -8.17% from the previous closing price in February, 2023. The high end is $284.00, and the low is $200.00. Even if you're not interested in SYK stock, you may be interested in its competitors.
-8.17% Downside

Stryker Corp Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, Stryker Corp's Price has seen an increase, rising from $212.28 to $233.61. This represents a growth of 10.05%. Analysts predict that Stryker Corp's Fair Value will increase in the upcoming year, reaching $280.90. This would represent an increase of 20.24%. Over the next eight years, experts predict that Stryker Corp's Fair Value will grow at a rate of 53.55%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
---|---|---|---|---|---|---|
EW Stock Forecast | Edwards Lifesciences | Outperform |
15
|
$82.12 | $92.45 | 13.25% |
ZBH Stock Forecast | Zimmer Biomet Holdings | Hold |
15
|
$129.45 | $130.09 | 0.42% |
MSA Stock Forecast | MSA Safety | Outperform |
18
|
$140.35 | $145.50 | 14.71% |
IART Stock Forecast | Integra LifeSciences Holdings | Hold |
16
|
$59.61 | $71.75 | 0.65% |
ENOV Stock Forecast | Enovis | Outperform |
15
|
$65.25 | $99.75 | 8.05% |
Stryker Corp Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Stryker Corp's Revenue has seen an increase, rising from $14.88B to $17.11B. This represents a growth of 14.94%. Analysts predict that Stryker Corp's Revenue will increase in the upcoming year, reaching $19.62B. This would represent an increase of 14.69%. Over the next eight years, experts predict that Stryker Corp's Revenue will grow at a rate of 37.62%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
---|---|---|---|---|---|---|
CYRX Stock Forecast | Cryoport | Buy |
8
|
$25.24 | $78.50 | 106.02% |
AVNS Stock Forecast | Avanos Medical | Hold |
11
|
$31.59 | $43.00 | 9.21% |
KIDS Stock Forecast | OrthoPediatrics | Outperform |
7
|
$48.62 | $0.00 | 43.97% |
Stryker Corp Dividend per Share Forecast for 2023 - 2025 - 2030
Stryker Corp's Dividend per Share has seen growth In the last two years, going from $2.14 to $2.59 – a gain of 21.03% In the next year, analysts believe that Dividend per Share will reach $3.07 – an increase of 18.53%. For the next eight years, the forecast is forDividend per Share to grow by 44.20%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
---|---|---|---|---|---|---|
XENT Stock Forecast | Intersect ENT | - |
6
|
$28.24 | $23.50 | 10.84% |
AORT Stock Forecast | Artivion | Outperform |
12
|
$14.03 | $29.15 | 113.83% |
ATEC Stock Forecast | Alphatec Holdings | Buy |
7
|
$13.48 | $0.00 | 40.95% |
Stryker Corp Free Cash Flow Forecast for 2023 - 2025 - 2030
Stryker Corp's Free Cash Flow has grown in the last two years, jumping from $1.54B to $2.74B – an increase of 77.56%. In the next year, analysts predict that Free Cash Flow will reach $3.59B – an increase of 30.99%. For the next eight years, the forecast is for Free Cash Flow to grow by 59.72%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
---|---|---|---|---|---|---|
SIBN Stock Forecast | SI-BONE | Buy |
6
|
$18.32 | $0.00 | 74.67% |
AXGN Stock Forecast | AxoGen | Outperform |
6
|
$9.29 | $20.00 | 115.29% |
IIN Stock Forecast | IntriCon | Buy |
10
|
$24.24 | $28.50 | 3.14% |
Stryker Corp Net Income Forecast for 2023 - 2025 - 2030
In the last two years, Stryker Corp's Net Income has seen a drop from $2.08B to $1.99B – a 4.27% decrease. In the coming year, analysts are expecting an increase in Net Income, predicting it will reach $4.17B – an increase of 109.24%. Over the next eight years, experts anticipate that Net Income growth for Stryker Corp will be 165.98%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
---|---|---|---|---|---|---|
SMTI Stock Forecast | Sanara MedTech | Buy |
11
|
$43.91 | $0.00 | 2.48% |
SPNE Stock Forecast | SeaSpine Holdings | Buy |
8
|
$9.54 | $28.61 | 120.13% |
UEEC Stock Forecast | United Health Products | - |
2
|
$0.25 | $0.00 | 128.00% |
Stryker Corp EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Stryker Corp's EBITDA has increased by 11.50%, going from $4.17B to $4.65B. In the next year, analysts are expecting an increase in EBITDA, predicting it will reach $5.60B – an increase of 20.62%. The Stryker Corp forecast is for EBITDA to reach $6.74B or grow by 45.11%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
---|---|---|---|---|---|---|
LAKE Stock Forecast | Lakeland Industries | Buy |
16
|
$14.49 | $28.00 | 93.24% |
SIEN Stock Forecast | Sientra | Buy |
6
|
$1.80 | $7.67 | 205.56% |
HCMC Stock Forecast | Healthier Choices Management | - |
0
|
$0.00 | $0.00 | 0.00% |
Stryker Corp EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Stryker Corp's EBIT has grown, increasing from $3.39B to $3.66B – an increase of 7.88%. For next year, the 21 analysts predict EBIT of $5.19B, which would mean an increase of 41.90%. Over the next eight years, the pros' prediction is EBITof $6.53B, which would mean a eight-year growth forecast of 78.67%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
---|---|---|---|---|---|---|
CFMS Stock Forecast | Conformis | Outperform |
0
|
$0.60 | $2.33 | 233.33% |
IVC Stock Forecast | Invacare | Outperform |
12
|
$1.31 | $5.08 | 358.02% |
SRGA Stock Forecast | Surgalign Holdings | Outperform |
8
|
$3.26 | $3.36 | 820.25% |
Stryker Corp EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, Stryker Corp's EPS has seen an increase, rising from $8.26 to $9.09. This represents a growth of 10.05%. Analysts predict that Stryker Corp's EPS will increase in the upcoming year, reaching $10.93. This would represent an increase of 20.24%. Over the next eight years, experts predict that Stryker Corp's EPS will grow at a rate of 53.55%.
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
---|---|---|---|---|---|---|
PETV Stock Forecast | PetVivo Holdings | Buy |
0
|
$2.35 | $0.00 | 197.87% |
RMTI Stock Forecast | Rockwell Medical | Buy |
7
|
$1.33 | $3.00 | 275.94% |
SINT Stock Forecast | Sintx Technologies | Buy |
10
|
$0.46 | $2.63 | 308.70% |